---
figid: PMC5220330__fimmu-07-00682-g001
figtitle: Interleukin-33 (IL-33)/ST2 signaling pathway
organisms:
- Human gammaherpesvirus 4
- Human papillomavirus
- Homo sapiens
- Mus musculus
- Nicotiana tabacum
- Helicobacter pylori
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC5220330
filename: fimmu-07-00682-g001.jpg
figlink: /pmc/articles/PMC5220330/figure/F1/
number: F1
caption: Interleukin-33 (IL-33)/ST2 signaling pathway. IL-33 is mainly expressed in
  the nucleus of epithelial and endothelial cells. IL-33 is released subsequent to
  cell damage, stress, or necrosis. Alternatively, IL-33 may be released under steady-state
  conditions—at low levels—via a so far unknown mechanism. Soluble IL-33 binds to
  its receptor, a heterodimeric complex comprising IL-1RL1/ST2 (ST2) and IL-1 receptor
  accessory protein (IL1RAP), thereby mobilizing downstream signaling molecules including
  MyD88 and TRAF-6, and eventually activating NF-κB, p38, JNK, and ERK pathways. Soluble
  ST2 acts as a decoy receptor for IL-33 to negatively regulate IL-33/ST2 signaling.
papertitle: The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.
reftext: Marie-Hélène Wasmer, et al. Front Immunol. 2016;7:682.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7647083
figid_alias: PMC5220330__F1
figtype: Figure
redirect_from: /figures/PMC5220330__F1
ndex: 78602a23-df2a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5220330__fimmu-07-00682-g001.html
  '@type': Dataset
  description: Interleukin-33 (IL-33)/ST2 signaling pathway. IL-33 is mainly expressed
    in the nucleus of epithelial and endothelial cells. IL-33 is released subsequent
    to cell damage, stress, or necrosis. Alternatively, IL-33 may be released under
    steady-state conditions—at low levels—via a so far unknown mechanism. Soluble
    IL-33 binds to its receptor, a heterodimeric complex comprising IL-1RL1/ST2 (ST2)
    and IL-1 receptor accessory protein (IL1RAP), thereby mobilizing downstream signaling
    molecules including MyD88 and TRAF-6, and eventually activating NF-κB, p38, JNK,
    and ERK pathways. Soluble ST2 acts as a decoy receptor for IL-33 to negatively
    regulate IL-33/ST2 signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL33
  - ST2
  - SULT2A1
  - IL1RL1
  - SDCBP2
  - IL1RAP
  - MYD88
  - IRAK1
  - IRAK4
  - TRAF6
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MAPK1
  - MAPK3
  - NFKB1
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - Il33
  - Il1rl1
  - Il1rap
  - Myd88
  - Irak1
  - Irak4
  - Traf6
  - Mapk8
  - Ephb2
  - Mapk1
  - Nfkb1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - il1rap
  - myd88
  - irak1
  - irak4
  - traf6
  - mapk8b
  - mapk14a
---
